Adam Simmons, MPH

  • 3Articles
  • 44.1KReads1
  • 2020–2023Active
  • 17Collaborators
  • 84Citations2

About

Adam Simmons, MPH, is affiliated with Alkermes, Inc. in Waltham, Massachusetts. Between 2020 and 2023, Simmons authored multiple articles focusing on schizophrenia and schizoaffective disorders, particularly examining treatments involving olanzapine combined with samidorphan. His work includes clinical trials assessing these treatments in various patient populations, including young adults early in their illness and individuals with comorbid alcohol use disorder. Simmons has frequently collaborated with co-authors such as David McDonnell and Bernard L. Silverman.

Publications

JCP
Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness
JCP
JCP

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.